AsiaNet-Pakistan Premier Editorial Content and Press Release Distribution Service
Apparel Group’s Announces New Record: Opens 350 New Stores in GCC & India, Forges 15 Strategic Global Brand Partnerships in 2023 DUBAI, United Arab Emirates, Jan. 08, 2024 (GLOBE NEWSWIRE) — Marking a year of unprecedented growth and ground-breaking initiatives, Apparel Group stands at the pinnacle of retail innovation and global expansion in 2023. The […]
Read More »ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EGRX
NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) between August 8, 2023 and November 28, 2023, both dates inclusive (the “Class Period”). A class action […]
Read More »CMI INVESTOR ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Cummins Inc. Investors to Inquire About Securities Class Action Investigation – CMI
NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Cummins Inc. (NYSE: CMI) resulting from allegations that Cummins may have issued materially misleading business information to the investing public. SO WHAT: If you purchased […]
Read More »ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages ACELYRIN, INC. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLRN
NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ACELYRIN, INC. (NASDAQ: SLRN) between May 4, 2023 and September 11, 2023, both dates inclusive (the “Class Period”), of the important January 16, 2024 lead plaintiff deadline. SO WHAT: If you purchased ACELYRIN […]
Read More »Recursion Adds New Chemical Entity Targeting Fibrotic Diseases to Late Discovery Pipeline
Potential First-in-Class Novel Molecule with Novel Target In-Licensed from Collaboration with Bayer SALT LAKE CITY, Jan. 04, 2024 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced it has signed an agreement with Bayer AG to in-license a new chemical entity that emerged from […]
Read More »New research harnesses AI and satellite imagery to reveal the expanding footprint of human activity at sea
Study reveals 75 percent of the world’s industrial fishing vessels are hidden from public view WASHINGTON, D.C., Jan. 03, 2024 (GLOBE NEWSWIRE) — A new study published today in the journal Nature offers an unprecedented view of previously unmapped industrial use of the ocean and how it is changing. The groundbreaking study, led by Global Fishing Watch, uses […]
Read More »Enovis Completes Acquisition of LimaCorporate S.p.A
WILMINGTON, Del., Jan. 03, 2024 (GLOBE NEWSWIRE) — Enovis™ Corporation (NYSE: ENOV, “Enovis” or the “Company”) an innovation-driven, medical technology growth company, today announced that it closed the acquisition of LimaCorporate S.p.A. (“Lima”), a privately held global orthopedic leader focused on restoring motion through an innovative portfolio of implant solutions. Lima strengthens Enovis’ position in the global orthopedic reconstruction […]
Read More »